Search

Your search keyword '"Kirwan, Peter"' showing total 249 results
Start Over Author "Kirwan, Peter" Language english
249 results on '"Kirwan, Peter"'

1. Protection of vaccine boosters and prior infection against mild/asymptomatic and moderate COVID-19 infection in the UK SIREN healthcare worker cohort: October 2023 to March 2024

Author

Kirwan, Peter D., Foulkes, Sarah, Munro, Katie, Sparkes, Dominic, Singh, Jasleen, Henry, Amanda, Dunne, Angela, Timeyin, Jean, Russell, Sophie, Khawam, Jameel, Blick, Debbie, Otter, Ashley D., Hettiarachchi, Nipunadi, Cairns, Michelle D., Jackson, Christopher H., Seaman, Shaun, Brown, Colin S., Atti, Ana, Islam, Jasmin, Charlett, Andre, De Angelis, Daniela, Presanis, Anne M., Hall, Victoria J., and Hopkins, Susan

Published
2024
Full Text
View/download PDF

2. Effect of second booster vaccinations and prior infection against SARS-CoV-2 in the UK SIREN healthcare worker cohort

Author

Lewis, Tracy, Bain, Steve, Thomas, Rebeccah, Geen, John, Pothecary, Carla, Cutler, Sean, Northfield, John, Price, Cathy, Tomlinson, Johanne, Knight, Sarah, Macnaughton, Emily, Watson, Ekaterina, Lazarus, Rajeka, Sinclair, Aaran, Galliford, Joanne, Masunda, Bridgett, Mahungu, Tabitha, Rodger, Alison, Hanison, Esther, Warren, Simon, Jain, Swati, Mirfenderesky, Mariyam, Mahabir, Natasha, Pritchard-Jones, Rowan, Wycherley, Diane, Gabriel, Claire, Matovu, Elijah, Bakker, Philippa, Guha, Simantee, Gormley, S., Pethick, James, Butt, Georgina, Pepper, Stacey, Bedford, Luke, Ridley, Paul, Democratis, Jane, Meda, Manjula, Chawla, Anu, Westwell, Fran, Kalakonda, Nagesh, Khanduri, Sheena, Doel, Allison, Pai, Sumita, Hacon, Christian, Nwaka, Davis, Moro, Veronica Mendez, Moody, A., Auckland, Cressida, Prince, Stephanie, de Silva, Thushan, Shulver, Helen, Shah, A., Jones, C., Subhro-Osuji, Banerjee, Houston, Angela, Planche, Tim, Booth, Martin, Duff, Christopher, Aeron-Thomas, Jonnie, Chaudhuri, Ray, Hilton, David, Jory, Hannah, Al-Khafaji, Zehra'a, Kemsley, Philippa, Longfellow, Ruth, Boss, David, Brake, Simon, Coke, Louise, Elumogo, Ngozi, Latham, Scott, Subudhi, Chinari, Hoad, Ina, Thomas, Claire, Chitalia, Nihil, Edmunds, Tracy, Ashby, Helen, Elliott, John, Wilkinson, Beverley, Rand, Abby, Thompson, Catherine, Agwuh, K., Grice, Anna, Moran, Kelly, Waykar, Vijayendra, Lester, Yvonne, Sach, Lauren, Court, Kathryn, White, Nikki, Favager, Clair, Holliday, Kyra, Harwood, Jayne, Payne, Brendan, Burns, Karen, Fothergill, Lynda, Arenas-Pinto, Alejandro, Severn, Abigail, Brown, Kerryanne, Gray, Katherine, Dare, Jane, Zheng, Qi, Hollinshead, Kathryn, Shorten, Robert, Roebuck, Alun, Holmes, Christopher, Wiselka, Martin, Faris, Barzo, Marsh, Liane, McAdam, Clare, Ditchfield, Lisa, Qazzafi, Zaman, Boyd, G., Wong, N., Brand, Sarah, Squires, Jack, Ashcroft, John, Rosario, Ismaelette Del, Howard, Joanne, Ward, Emma, Harrison, Gemma, Morgan, Joely, Corless, Claire, Penn, Ruth, Wong, Nick, Bagary, Manny, Starkova, Nadezda, Beekes, Mandy, Carnahan, Mandy, Khan, Shivani, Mackay, Shekoo, Lewis, Keneisha, Pickard, Graham, Dawson, Joy, Finlayson, Lauren, Cameron, Euan, Todd, Anne, Fagegaltier, Sebastien, Mavin, Sally, Cochrane, Alexandra, Gibson, Andrew, Donaldson, Sam, Templeton, Kate, Malcolm, Martin, Smith, Beth, Dhasmana, Devesh, Fowler, Susan, Ho, Antonia, Murphy, Michael, Beith, Claire, Patel, Manish, Boyd, Elizabeth, Irvine, Val, Grant, Alison, Temple-Purcell, Rebecca, Loughrey, Clodagh, Hanna, Elinor, Johnston, Frances, Boulos, Angel, Thompson, Fiona, Protaschik, Yuri, Regan, Susan, Donaghy, Tracy, O'Kane, Maurice, Akinbami, Omolola, Barbero, Paola, Brooks, Tim, Chand, Meera, Insalata, Ferdinando, Joshi, Palak, O'Connell, Anne-Marie, Ramsay, Mary, Saei, Ayoub, Zambon, Maria, Linley, Ezra, Tonge, Simon, Adaji, Enemona, Adebiyi, Omoyeni, Andrews, Nick, Conneely, Joanna, Conneely, Paul, Dunne, Angela, Dyer, Simone, Emmett, Hannah, Hettiarachchi, Nipunadi, Kapirial, Nishanthan, Khawam, Jameel, Monk, Edward, Russell, Sophie, Taylor-Kerr, Andrew, Timeyin, Jean, D'Arcangelo, Silvia, Rowe, Cathy, Semper, Amanda, Gallagher, Eileen, Kyffin, Robert, Cromey, Lisa, Areghan, Desmond, Bishop, Jennifer, Dembinsky, Melanie, Dobbie, Laura, Evans, Josie, Goldberg, David, Haahr, Lynne, Jorgenson, Annelysse, Matuluko, Ayodeji, Naismith, Laura, Nuryunarsih, Desy, Olaoye, Alexander, Plank, Caitlin, Price, Lesley, Sergenson, Nicole, Stewart, Sally, Telfer, Andrew, Weir, Jennifer, De Lacy, Ellen, Ellis, Yvette, Froude, Susannah, Stevens, Guy, Tyson, Linda, Dunachie, Susanna, Klenerman, Paul, Duncan, Chris, Payne, Rebecca, Turtle, Lance, Richter, Alex, De Silva, Thushan, Barnes, Eleanor, Wootton, Daniel, Galgut, Oliver, Heeney, Jonathan, Baxendale, Helen, Castillo-Olivares, Javier, Beale, Rupert, Carr, Edward, Barclay, Wendy, Moshe, Maya, Palmarini, Massimo, Willett, Brian, Baillie, John Kenneth, Evans, Jennie, Aquino, Erika, Kirwan, Peter D., Hall, Victoria J., Foulkes, Sarah, Otter, Ashley D., Munro, Katie, Sparkes, Dominic, Howells, Anna, Platt, Naomi, Broad, Jonathan, Crossman, David, Norman, Chris, Corrigan, Diane, Jackson, Christopher H., Cole, Michelle, Brown, Colin S., Atti, Ana, Islam, Jasmin, Presanis, Anne M., Charlett, Andre, De Angelis, Daniela, and Hopkins, Susan

Published
2024
Full Text
View/download PDF

3. Effectiveness of BNT162b2 mRNA vaccine third doses and previous infection in protecting against SARS-CoV-2 infections during the Delta and Omicron variant waves; the UK SIREN cohort study September 2021 to February 2022

Author

Hall, Victoria J., Insalata, Ferdinando, Foulkes, Sarah, Kirwan, Peter, Sparkes, Dominic, Atti, Ana, Cole, Michelle, de Lacy, Elen, Price, Lesley, Corrigan, Diane, Brown, Colin S., Islam, Jasmin, Charlett, Andre, and Hopkins, Susan

Published
2024
Full Text
View/download PDF

5. Free HIV self-test for identification and linkage to care of previously undetected HIV infection in men who have sex with men in England and Wales (SELPHI): an open-label, internet-based, randomised controlled trial

Author

Rodger, Alison J, McCabe, Leanne, Phillips, Andrew N, Lampe, Fiona C, Burns, Fiona, Ward, Denise, Delpech, Valerie, Weatherburn, Peter, Witzel, T Charles, Pebody, Roger, Kirwan, Peter, Gabriel, Michelle, Khawam, Jameel, Brady, Michael, Fenton, Kevin A, Trevelion, Roy, Collaco-Moraes, Yolanda, McCormack, Sheena, and Dunn, David

Published
2022
Full Text
View/download PDF

6. A reference human induced pluripotent stem cell line for large-scale collaborative studies

Author

Pantazis, Caroline B., Yang, Andrian, Lara, Erika, McDonough, Justin A., Blauwendraat, Cornelis, Peng, Lirong, Oguro, Hideyuki, Kanaujiya, Jitendra, Zou, Jizhong, Sebesta, David, Pratt, Gretchen, Cross, Erin, Blockwick, Jeffrey, Buxton, Philip, Kinner-Bibeau, Lauren, Medura, Constance, Tompkins, Christopher, Hughes, Stephen, Santiana, Marianita, Faghri, Faraz, Nalls, Mike A., Vitale, Daniel, Ballard, Shannon, Qi, Yue A., Ramos, Daniel M., Anderson, Kailyn M., Stadler, Julia, Narayan, Priyanka, Papademetriou, Jason, Reilly, Luke, Nelson, Matthew P., Aggarwal, Sanya, Rosen, Leah U., Kirwan, Peter, Pisupati, Venkat, Coon, Steven L., Scholz, Sonja W., Priebe, Theresa, Öttl, Miriam, Dong, Jian, Meijer, Marieke, Janssen, Lara J.M., Lourenco, Vanessa S., van der Kant, Rik, Crusius, Dennis, Paquet, Dominik, Raulin, Ana-Caroline, Bu, Guojun, Held, Aaron, Wainger, Brian J., Gabriele, Rebecca M.C., Casey, Jackie M., Wray, Selina, Abu-Bonsrah, Dad, Parish, Clare L., Beccari, Melinda S., Cleveland, Don W., Li, Emmy, Rose, Indigo V.L., Kampmann, Martin, Calatayud Aristoy, Carles, Verstreken, Patrik, Heinrich, Laurin, Chen, Max Y., Schüle, Birgitt, Dou, Dan, Holzbaur, Erika L.F., Zanellati, Maria Clara, Basundra, Richa, Deshmukh, Mohanish, Cohen, Sarah, Khanna, Richa, Raman, Malavika, Nevin, Zachary S., Matia, Madeline, Van Lent, Jonas, Timmerman, Vincent, Conklin, Bruce R., Johnson Chase, Katherine, Zhang, Ke, Funes, Salome, Bosco, Daryl A., Erlebach, Lena, Welzer, Marc, Kronenberg-Versteeg, Deborah, Lyu, Guochang, Arenas, Ernest, Coccia, Elena, Sarrafha, Lily, Ahfeldt, Tim, Marioni, John C., Skarnes, William C., Cookson, Mark R., Ward, Michael E., and Merkle, Florian T.

Published
2022
Full Text
View/download PDF

10. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK

Author

Baillie, J Kenneth, Semple, Malcolm G, Openshaw, Peter JM, Carson, Gail, Alex, Beatrice, Bach, Benjamin, Barclay, Wendy S, Bogaert, Debby, Chand, Meera, Cooke, Graham S, Docherty, Annemarie B, Dunning, Jake, da Silva Filipe, Ana, Fletcher, Tom, Green, Christopher A, Harrison, Ewen M, Hiscox, Julian A, Ho, Antonia YW, Horby, Peter W, Ijaz, Samreen, Khoo, Say, Klenerman, Paul, Law, Andrew, Lim, Wei Shen, Mentzer, Alexander J, Merson, Laura, Meynert, Alison M, Noursadeghi, Mahdad, Moore, Shona C, Palmarini, Massimo, Paxton, William A, Pollakis, Georgios, Price, Nicholas, Rambaut, Andrew, Robertson, David L, Russell, Clark D, Sancho-Shimizu, Vanessa, Scott, Janet T, de Silva, Thushan, Sigfrid, Louise, Solomon, Tom, Sriskandan, Shiranee, Stuart, David, Summers, Charlotte, Tedder, Richard S, Thomson, Emma C, Thompson, AA Roger, Thwaites, Ryan S, Turtle, Lance CW, Gupta, Rishi K, Palmieri, Carlo, Zambon, Maria, Hardwick, Hayley, Donohue, Chloe, Lyons, Ruth, Griffiths, Fiona, Oosthuyzen, Wilna, Norman, Lisa, Pius, Riinu, Drake, Thomas M, Fairfield, Cameron J, Knight, Stephen R, Mclean, Kenneth A, Murphy, Derek, Shaw, Catherine A, Dalton, Jo, Girvan, Michelle, Saviciute, Egle, Roberts, Stephanie, Harrison, Janet, Marsh, Laura, Connor, Marie, Halpin, Sophie, Jackson, Clare, Gamble, Carrol, Leeming, Gary, Wham, Murray, Clohisey, Sara, Hendry, Ross, Scott-Brown, James, Greenhalf, William, Shaw, Victoria, McDonald, Sarah E, Keating, Seán, Ahmed, Katie A, Armstrong, Jane A, Ashworth, Milton, Asiimwe, Innocent G, Bakshi, Siddharth, Barlow, Samantha L, Booth, Laura, Brennan, Benjamin, Bullock, Katie, Catterall, Benjamin WA, Clark, Jordan J, Clarke, Emily A, Cole, Sarah, Cooper, Louise, Cox, Helen, Davis, Christopher, Dincarslan, Oslem, Dunn, Chris, Dyer, Philip, Elliott, Angela, Evans, Anthony, Finch, Lorna, Fisher, Lewis WS, Foster, Terry, Garcia-Dorival, Isabel, Gunning, Philip, Hartley, Catherine, Jensen, Rebecca L, Jones, Christopher B, Jones, Trevor R, Khandaker, Shadia, King, Katharine, Kiy, Robyn T, Koukorava, Chrysa, Lake, Annette, Lant, Suzannah, Latawiec, Diane, Lavelle-Langham, Lara, Lefteri, Daniella, Lett, Lauren, Livoti, Lucia A, Mancini, Maria, McDonald, Sarah, McEvoy, Laurence, McLauchlan, John, Metelmann, Soeren, Miah, Nahida S, Middleton, Joanna, Mitchell, Joyce, Murphy, Ellen G, Penrice-Randal, Rebekah, Pilgrim, Jack, Prince, Tessa, Reynolds, Will, Ridley, P. Matthew, Sales, Debby, Shaw, Victoria E, Shears, Rebecca K, Small, Benjamin, Subramaniam, Krishanthi S, Szemiel, Agnieska, Taggart, Aislynn, Tanianis-Hughes, Jolanta, Thomas, Jordan, Trochu, Erwan, van Tonder, Libby, Wilcock, Eve, Zhang, J. Eunice, Flaherty, Lisa, Maziere, Nicole, Cass, Emily, Doce Carracedo, Alejandra, Carlucci, Nicola, Holmes, Anthony, Massey, Hannah, Murphy, Lee, Wrobel, Nicola, McCafferty, Sarah, Morrice, Kirstie, MacLean, Alan, Adeniji, Kayode, Agranoff, Daniel, Agwuh, Ken, Ail, Dhiraj, Aldera, Erin L, Alegria, Ana, Angus, Brian, Ashish, Abdul, Atkinson, Dougal, Bari, Shahedal, Barlow, Gavin, Barnass, Stella, Barrett, Nicholas, Bassford, Christopher, Basude, Sneha, Baxter, David, Beadsworth, Michael, Bernatoniene, Jolanta, Berridge, John, Best, Nicola, Bothma, Pieter, Chadwick, David, Brittain-Long, Robin, Bulteel, Naomi, Burden, Tom, Burtenshaw, Andrew, Caruth, Vikki, Chambler, Duncan, Chee, Nigel, Child, Jenny, Chukkambotla, Srikanth, Clark, Tom, Collini, Paul, Cosgrove, Catherine, Cupitt, Jason, Cutino-Moguel, Maria-Teresa, Dark, Paul, Dawson, Chris, Dervisevic, Samir, Donnison, Phil, Douthwaite, Sam, DuRand, Ingrid, Dushianthan, Ahilanadan, Dyer, Tristan, Evans, Cariad, Eziefula, Chi, Fegan, Chrisopher, Finn, Adam, Fullerton, Duncan, Garg, Sanjeev, Garg, Atul, Gkrania-Klotsas, Effrossyni, Godden, Jo, Goldsmith, Arthur, Graham, Clive, Hardy, Elaine, Hartshorn, Stuart, Harvey, Daniel, Havalda, Peter, Hawcutt, Daniel B, Hobrok, Maria, Hodgson, Luke, Hormis, Anil, Jacobs, Michael, Jain, Susan, Jennings, Paul, Kaliappan, Agilan, Kasipandian, Vidya, Kegg, Stephen, Kelsey, Michael, Kendall, Jason, Kerrison, Caroline, Kerslake, Ian, Koch, Oliver, Koduri, Gouri, Koshy, George, Laha, Shondipon, Laird, Steven, Larkin, Susan, Leiner, Tamas, Lillie, Patrick, Limb, James, Linnett, Vanessa, Little, Jeff, Lyttle, Mark, MacMahon, Michael, MacNaughton, Emily, Mankregod, Ravish, Masson, Huw, Matovu, Elijah, McCullough, Katherine, McEwen, Ruth, Meda, Manjula, Mills, Gary, Minton, Jane, Mirfenderesky, Mariyam, Mohandas, Kavya, Mok, Quen, Moon, James, Moore, Elinoor, Morgan, Patrick, Morris, Craig, Mortimore, Katherine, Moses, Samuel, Mpenge, Mbiye, Mulla, Rohinton, Murphy, Michael, Nagel, Megan, Nagarajan, Thapas, Nelson, Mark, O'Shea, Matthew K, Otahal, Igor, Ostermann, Marlies, Pais, Mark, Panchatsharam, Selva, Papakonstantinou, Danai, Paraiso, Hassan, Patel, Brij, Pattison, Natalie, Pepperell, Justin, Peters, Mark, Phull, Mandeep, Pintus, Stefania, Singh Pooni, Jagtur, Post, Frank, Price, David, Prout, Rachel, Rae, Nikolas, Reschreiter, Henrik, Reynolds, Tim, Richardson, Neil, Roberts, Mark, Roberts, Devender, Rose, Alistair, Rousseau, Guy, Ryan, Brendan, Saluja, Taranprit, Shah, Aarti, Shanmuga, Prad, Sharma, Anil, Shawcross, Anna, Sizer, Jeremy, Shankar-Hari, Manu, Smith, Richard, Snelson, Catherine, Spittle, Nick, Staines, Nikki, Stambach, Tom, Stewart, Richard, Subudhi, Pradeep, Szakmany, Tamas, Tatham, Kate, Thomas, Jo, Thompson, Chris, Thompson, Robert, Tridente, Ascanio, Tupper-Carey, Darell, Twagira, Mary, Ustianowski, Andrew, Vallotton, Nick, Vincent-Smith, Lisa, Visuvanathan, Shico, Vuylsteke, Alan, Waddy, Sam, Wake, Rachel, Walden, Andrew, Welters, Ingeborg, Whitehouse, Tony, Whittaker, Paul, Whittington, Ashley, Papineni, Padmasayee, Wijesinghe, Meme, Williams, Martin, Wilson, Lawrence, Sarah, Sarah, Winchester, Stephen, Wiselka, Martin, Wolverson, Adam, Wooton, Daniel G, Workman, Andrew, Yates, Bryan, Young, Peter, Mulholland, Rachel H, Lone, Nazir I, Cheyne, Christopher P, De Angelis, Daniela, Diaz-Ordaz, Karla, Donegan, Cara, Funk, Sebastian, García-Fiñana, Marta, Hardwick, Hayley E, Ho, Antonia, Hughes, David M, Keogh, Ruth H, Kirwan, Peter D, Nguyen Van-Tam, Jonathan S, Spencer, Rebecca G, Tom, Brian DM, and Turtle, Lance

Published
2021
Full Text
View/download PDF

12. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)

Author

Andrews, N, Atti, A, Aziz, H, Brooks, T, Brown, CS, Camero, D, Carr, C, Chand, MA, Charlett, A, Crawford, H, Cole, M, Conneely, J, D'Arcangelo, S, Ellis, J, Evans, S, Foulkes, S, Gillson, N, Gopal, R, Hall, L, Hall, VJ, Harrington, P, Hopkins, S, Hewson, J, Hoschler, K, Ironmonger, D, Islam, J, Kall, M, Karagiannis, I, Kay, O, Khawam, J, King, E, Kirwan, P, Kyffin, R, Lackenby, A, Lattimore, M, Linley, E, Lopez-Bernal, J, Mabey, L, McGregor, R, Miah, S, Monk, EJM, Munro, K, Naheed, Z, Nissr, A, O'Connell, AM, Oguti, B, Okafor, H, Organ, S, Osbourne, J, Otter, A, Patel, M, Platt, S, Pople, D, Potts, K, Ramsay, M, Robotham, J, Rokadiya, S, Rowe, C, Saei, A, Sebbage, G, Semper, A, Shrotri, M, Simmons, R, Soriano, A, Staves, P, Taylor, S, Taylor, A, Tengbe, A, Tonge, S, Vusirikala, A, Wallace, S, Wellington, E, Zambon, M, Corrigan, D, Sartaj, M, Cromey, L, Campbell, S, Braithwaite, K, Price, L, Haahr, L, Stewart, S, Lacey, ED, Partridge, L, Stevens, G, Ellis, Y, Hodgson, H, Norman, C, Larru, B, Mcwilliam, S, Winchester, S, Cieciwa, P, Pai, A, Loughrey, C, Watt, A, Adair, F, Hawkins, A, Grant, A, Temple-Purcell, R, Howard, J, Slawson, N, Subudhi, C, Davies, S, Bexley, A, Penn, R, Wong, N, Boyd, G, Rajgopal, A, Arenas-Pinto, A, Matthews, R, Whileman, A, Laugharne, R, Ledger, J, Barnes, T, Jones, C, Botes, D, Chitalia, N, Akhtar, S, Harrison, G, Horne, S, Walker, N, Agwuh, K, Maxwell, V, Graves, J, Williams, S, O'Kelly, A, Ridley, P, Cowley, A, Johnstone, H, Swift, P, Democratis, J, Meda, M, Callens, C, Beazer, S, Hams, S, Irvine, V, Chandrasekaran, B, Forsyth, C, Radmore, J, Thomas, C, Brown, K, Roberts, S, Burns, P, Gajee, K, Byrne, TM, Sanderson, F, Knight, S, Macnaughton, E, Burton, BJL, Smith, H, Chaudhuri, R, Hollinshead, K, Shorten, RJ, Swan, A, Favager, C, Murira, J, Baillon, S, Hamer, S, Gantert, K, Russell, J, Brennan, D, Dave, A, Chawla, A, Westell, F, Adeboyeku, D, Papineni, P, Pegg, C, Williams, M, Ahmad, S, Ingram, S, Gabriel, C, Pagget, K, Maloney, G, Ashcroft, J, Del Rosario, I, Crosby-Nwaobi, R, Reeks, C, Fowler, S, Prentice, L, Spears, M, McKerron, G, McLelland-Brooks, K, Anderson, J, Donaldson, S, Templeton, K, Coke, L, Elumogo, N, Elliott, J, Padgett, D, Mirfenderesky, M, Cross, A, Price, J, Joyce, S, Sinanovic, I, Howard, M, Lewis, T, Cowling, P, Potoczna, D, Brand, S, Sheridan, L, Wadams, B, Lloyd, A, Mouland, J, Giles, J, Pottinger, G, Coles, H, Joseph, M, Lee, M, Orr, S, Chenoweth, H, Auckland, C, Lear, R, Mahungu, T, Rodger, A, Penny-Thomas, K, Pai, S, Zamikula, J, Smith, E, Stone, S, Boldock, E, Howcroft, D, Thompson, C, Aga, M, Domingos, P, Gormley, S, Kerrison, C, Marsh, L, Tazzyman, S, Allsop, L, Ambalkar, S, Beekes, M, Jose, S, Tomlinson, J, Jones, A, Price, C, Pepperell, J, Schultz, M, Day, J, Boulos, A, Defever, E, McCracken, D, Gray, K, Houston, A, Planche, T, Pritchard Jones, R, Wycherley, Diane, Bennett, S, Marrs, J, Nimako, K, Stewart, B, Kalakonda, N, Khanduri, S, Ashby, A, Holden, M, Mahabir, N, Harwood, J, Payne, B, Court, K, Staines, N, Longfellow, R, Green, ME, Hughes, LE, Halkes, M, Mercer, P, Roebuck, A, Wilson-Davies, E, Gallego, L, Lazarus, R, Aldridge, N, Berry, L, Game, F, Reynolds, T, Holmes, C, Wiselka, M, Higham, A, Booth, M, Duff, C, Alderton, J, Jory, H, Virgilio, E, Chin, T, Qazzafi, MZ, Moody, AM, Tilley, R, Donaghy, T, Shipman, K, Sierra, R, Jones, N, Mills, G, Harvey, D, Huang, YWJ, Birch, J, Robinson, L, Board, S, Broadley, A, Laven, C, Todd, N, Eyre, DW, Jeffery, K, Dunachie, S, Duncan, C, Klenerman, P, Turtle, L, De Silva, T, Baxendale, H, Heeney, JL, Hall, Victoria Jane, Foulkes, Sarah, Charlett, Andre, Atti, Ana, Monk, Edward J M, Simmons, Ruth, Wellington, Edgar, Cole, Michelle J, Saei, Ayoub, Oguti, Blanche, Munro, Katie, Wallace, Sarah, Kirwan, Peter D, Shrotri, Madhumita, Vusirikala, Amoolya, Rokadiya, Sakib, Kall, Meaghan, Zambon, Maria, Ramsay, Mary, Brooks, Tim, Brown, Colin S, Chand, Meera A, and Hopkins, Susan

Published
2021
Full Text
View/download PDF

17. Shakespeare and the idea of apocrypha : negotiating the boundaries of the dramatic canon

Author

Kirwan, Peter

Subjects
820.9003, PR English literature
Abstract

Shakespeare and the Idea of Apocrypha offers the most comprehensive study to date of an intriguing but understudied body of plays. It undertakes a major reconsideration of the processes that determine the constitution of the Shakespeare canon through study of that canon’s exclusions. This thesis combines historical analysis of the emergence and development of the "Shakespeare Apocrypha" with current theorisations of dramatic collaboration. Several new theoretical and historical approaches to early modern authorship have emerged in the last decade. This thesis breaks new ground by bringing them together to demonstrate the untenability of the dichotomy between Canon and Apocrypha. Both within and without the text, the author is only one of several factors that shape the plays, and canonical boundaries are contingent rather than absolute. Chapter One draws on the New Textualism and studies of material print attributions, viewing the construction of the apocryphal canon alongside the growth of Shakespeare’s cultural prestige over three centuries. Chapter Two applies recent repertory studies to authorship questions, treating five anonymous King’s Men’s plays as part of a shared company practice that transcends authorial divisions. Chapter Three seeks dialogue between post-structuralist theory and "disintegrationist" work, revealing a shared concern with the plurality of agents within disputed plays. Within all three models of authorship, the divisions between "Shakespeare" and "not Shakespeare" are shown to be ambiguous and subjective. The associations of many disputed plays with the Shakespeare canon are factual, not fanciful. The ambiguity of canonical boundaries ultimately demonstrates the insufficiency of the "CompleteWorks" model for study of Shakespeare’s drama. Chapter Four confronts the commercial considerations that impose practical limitations on the organisation of plays. In so doing, this thesis establishes the theoretical principles by which the neglected plays of the Apocrypha can be readmitted into discourse, dispersing the fixed authority of the authorial canon.

Published
2011

19. Insidious Risk of Severe Mycobacterium chimaera Infection in Cardiac Surgery Patients

Author

Chand, Meera, Lamagni, Theresa, Kranzer, Katharina, Hedge, Jessica, Moore, Ginny, Parks, Simon, Collins, Samuel, del Ojo Elias, Carlos, Ahmed, Nada, Brown, Tim, Smith, E. Grace, Hoffman, Peter, Kirwan, Peter, Mason, Brendan, Smith-Palmer, Alison, Veal, Philip, Lalor, Maeve K., Bennett, Allan, Walker, James, Yeap, Alicia, Martin, Antonio Isidro Carrion, Dolan, Gayle, Bhatt, Sonia, Skingsley, Andrew, Charlett, André, Pearce, David, Russell, Katherine, Kendall, Simon, Klein, Andrew A., Robins, Stephen, Schelenz, Silke, Newsholme, William, Thomas, Stephanie, Collyns, Tim, Davies, Eleri, McMenamin, Jim, Doherty, Lorraine, Peto, Tim E. A., Crook, Derrick, Zambon, Maria, and Phin, Nick

Published
2017

22. A reference human induced pluripotent stem cell line for collaborative studies

Author

Pantazis, Caroline B, Yang, Andrian, Lara, Erika, McDonough, Justin A, Blauwendraat, Cornelis, Peng, Lirong, Oguro, Hideyuki, Kanaujiya, Jitendra, Zou, Jizhong, Sebesta, David, Pratt, Gretchen, Cross, Erin, Blockwick, Jeffrey, Buxton, Philip, Kinner-Bibeau, Lauren, Medura, Constance, Tompkins, Christopher, Hughes, Stephen, Santiana, Marianita, Faghri, Faraz, Nalls, Mike A, Vitale, Daniel, Ballard, Shannon, Qi, Yue A, Ramos, Daniel M, Anderson, Kailyn M, Stadler, Julia, Narayan, Priyanka, Papademetriou, Jason, Reilly, Luke, Nelson, Matthew P, Aggarwal, Sanya, Rosen, Leah U, Kirwan, Peter, Pisupati, Venkat, Coon, Steven L, Scholz, Sonja W, Priebe, Theresa, Ottl, Miriam, Dong, Jian, Meijer, Marieke, Janssen, Lara JM, Lourenco, Vanessa S, van der Kant, Rik, Crusius, Dennis, Paquet, Dominik, Raulin, Ana-Caroline, Bu, Guojun, Held, Aaron, Wainger, Brian J, Gabriele, Rebecca MC, Casey, Jackie M, Wray, Selina, Abu-Bonsrah, Dad, Parish, Clare L, Beccari, Melinda S, Cleveland, Don W, Li, Emmy, Rose, Indigo VL, Kampmann, Martin, Aristoy, Carles Calatayud, Verstreken, Patrik, Heinrich, Laurin, Chen, Max Y, Schule, Birgitt, Dou, Dan, Holzbaur, Erika LF, Zanellati, Maria Clara, Basundra, Richa, Deshmukh, Mohanish, Cohen, Sarah, Khanna, Richa, Raman, Malavika, Nevin, Zachary S, Matia, Madeline, Van Lent, Jonas, Timmerman, Vincent, Conklin, Bruce R, Chase, Katherine Johnson, Zhang, Ke, Funes, Salome, Bosco, Daryl A, Erlebach, Lena, Welzer, Marc, Kronenberg-Versteeg, Deborah, Lyu, Guochang, Arenas, Ernest, Coccia, Elena, Sarrafha, Lily, Ahfeldt, Tim, Marioni, John C, Skarnes, William C, Cookson, Mark R, Ward, Michael E, and Merkle, Florian T

Subjects
Science & Technology, Cell Biology, DOPAMINE NEURONS, RISK LOCI, GENE, DISEASE, DIRECTIONAL GENOMIC HYBRIDIZATION, COPY NUMBER, DIFFERENTIATION, Cell & Tissue Engineering, HETEROGENEITY, Life Sciences & Biomedicine, A-BETA, GENERATION
Abstract

Human induced pluripotent stem cell (iPSC) lines are a powerful tool for studying development and disease, but the considerable phenotypic variation between lines makes it challenging to replicate key findings and integrate data across research groups. To address this issue, we sub-cloned candidate human iPSC lines and deeply characterized their genetic properties using whole genome sequencing, their genomic stability upon CRISPR-Cas9-based gene editing, and their phenotypic properties including differentiation to commonly used cell types. These studies identified KOLF2.1J as an all-around well-performing iPSC line. We then shared KOLF2.1J with groups around the world who tested its performance in head-to-head comparisons with their own preferred iPSC lines across a diverse range of differentiation protocols and functional assays. On the strength of these findings, we have made KOLF2.1J and its gene-edited derivative clones readily accessible to promote the standardization required for large-scale collaborative science in the stem cell field. ispartof: CELL STEM CELL vol:29 issue:12 pages:1685-+ ispartof: location:United States status: published

Published
2022

23. From the General Editor Going Public.

Author

Kirwan, Peter

Subjects
PSYCHOLOGICAL resilience, PERFORMING arts, THEATERS, AUDITORIUMS
Abstract

The article offers information on realm of Shakespearean theater, emphasizing its impact on communities and its resilience amid challenges. Topics include the Shakespeare Bulletin's special issue on "Public Shakespeare and Performance," which delves into the viability; the financial and political threats faced by theaters and arts and humanities departments; and the submissions received by the Shakespeare Association of America's 2024 Shakespeare Publics Award committee.

Published
2024
Full Text
View/download PDF

31. From the General Editor: "The land is burning".

Author

Kirwan, Peter

Subjects
SCHOLARLY periodicals, DRAMATIC productions of Shakespeare's plays, PERFORMANCE evaluation
Abstract

This editorial reflects on community-forming in relation to Shakespeare performance, from the role played by Shakespeare Bulletin over its forty-year history, to the contingencies and vulnerabilities revealed by the environmental catastrophes of summer 2023. The editorial also introduces changes to the Shakespeare Bulletin team, welcoming Hailey Bachrach and Benjamin Broadribb as the new editors of the journal's performance reviews section. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

33. Afterword: "Your time's expired": Spatiotemporal Dramaturgies of the Contemporary.

Author

Kirwan, Peter

Subjects
DRAMATIC structure, FUZZY languages, RELEVANCE
Abstract

This afterword responds to the contents of this special issue by returning to Jan Kott's Szkice o Szekspirze and exploring the fuzzy language around contemporaneity, resonance, and relevance. Contemporaneity in theatrical productions often manifests in either very vague or very specific terms, and often serves a predominantly aesthetic function. Taking the cue of Shakespeare's time-skipping later plays Pericles and The Winter's Tale —both of which resist a straightforward depiction of a "now"—and focusing on Cheek by Jowl's 2018–19 Périclès, Prince de Tyr , this afterword draws together the arguments made throughout this special issue to propose a model of contemporaneity as experiential immediacy, which aligns with recent attempts to understand contemporaneity at the point of reception. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

34. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK

Author

Docherty, Annemarie B, Mulholland, Rachel H, Lone, Nazir I, Cheyne, Christopher P, De Angelis, Daniela, Diaz-Ordaz, Karla, Donegan, Cara, Drake, Thomas M, Dunning, Jake, Funk, Sebastian, García-Fiñana, Marta, Girvan, Michelle, Hardwick, Hayley E, Harrison, Janet, Ho, Antonia, Hughes, David M, Keogh, Ruth H, Kirwan, Peter D, Leeming, Gary, Nguyen Van-Tam, Jonathan S, Pius, Riinu, Russell, Clark D, Spencer, Rebecca G, Tom, Brian Dm, Turtle, Lance, Openshaw, Peter Jm, Baillie, J Kenneth, Harrison, Ewen M, Semple, Malcolm G, and ISARIC4C Investigators

Abstract

BACKGROUND: Mortality rates in hospitalised patients with COVID-19 in the UK appeared to decline during the first wave of the pandemic. We aimed to quantify potential drivers of this change and identify groups of patients who remain at high risk of dying in hospital. METHODS: In this multicentre prospective observational cohort study, the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK recruited a prospective cohort of patients with COVID-19 admitted to 247 acute hospitals in England, Scotland, and Wales during the first wave of the pandemic (between March 9 and Aug 2, 2020). We included all patients aged 18 years and older with clinical signs and symptoms of COVID-19 or confirmed COVID-19 (by RT-PCR test) from assumed community-acquired infection. We did a three-way decomposition mediation analysis using natural effects models to explore associations between week of admission and in-hospital mortality, adjusting for confounders (demographics, comorbidities, and severity of illness) and quantifying potential mediators (level of respiratory support and steroid treatment). The primary outcome was weekly in-hospital mortality at 28 days, defined as the proportion of patients who had died within 28 days of admission of all patients admitted in the observed week, and it was assessed in all patients with an outcome. This study is registered with the ISRCTN Registry, ISRCTN66726260. FINDINGS: Between March 9, and Aug 2, 2020, we recruited 80 713 patients, of whom 63 972 were eligible and included in the study. Unadjusted weekly in-hospital mortality declined from 32·3% (95% CI 31·8-32·7) in March 9 to April 26, 2020, to 16·4% (15·0-17·8) in June 15 to Aug 2, 2020. Reductions in mortality were observed in all age groups, in all ethnic groups, for both sexes, and in patients with and without comorbidities. After adjustment, there was a 32% reduction in the risk of mortality per 7-week period (odds ratio [OR] 0·68 [95% CI 0·65-0·71]). The higher proportions of patients with severe disease and comorbidities earlier in the first wave (March and April) than in June and July accounted for 10·2% of this reduction. The use of respiratory support changed during the first wave, with gradually increased use of non-invasive ventilation over the first wave. Changes in respiratory support and use of steroids accounted for 22·2%, OR 0·95 (0·94-0·95) of the reduction in in-hospital mortality. INTERPRETATION: The reduction in in-hospital mortality in patients with COVID-19 during the first wave in the UK was partly accounted for by changes in the case-mix and illness severity. A significant reduction in in-hospital mortality was associated with differences in respiratory support and critical care use, which could partly reflect accrual of clinical knowledge. The remaining improvement in in-hospital mortality is not explained by these factors, and could be associated with changes in community behaviour, inoculum dose, and hospital capacity strain. FUNDING: National Institute for Health Research and the Medical Research Council.

Published
2021

35. Re‐assessing the late HIV diagnosis surveillance definition in the era of increased and frequent testing.

Author

Kirwan, Peter D., Croxford, Sara, Aghaizu, Adamma, Murphy, Gary, Tosswill, Jennifer, Brown, Alison E., and Delpech, Valerie C.

Subjects
*DIAGNOSIS of HIV infections, *DELAYED diagnosis, *PUBLIC health surveillance, *HIV infections, *BIOMARKERS, *CLINICAL pathology, *HIV-positive persons, *TIME, *SEROCONVERSION, *MEDICAL screening, *RISK assessment, *SEX distribution, *CD4 lymphocyte count, *GAY people, MORTALITY risk factors
Abstract

Objectives: Late HIV diagnosis (CD4 <350 cells/mm3) is a key public health metric. In an era of more frequent testing, the likelihood of HIV diagnosis occurring during seroconversion, when CD4 counts may dip below 350, is greater. We applied a correction, considering markers of recent infection, and re‐assessed 1‐year mortality following late diagnosis. Methods: We used national epidemiological and laboratory surveillance data from all people diagnosed with HIV in England, Wales, and Northern Ireland (EW&NI). Those with a baseline CD4 <350 were reclassified as 'not late' if they had evidence of recent infection (recency test and/or negative test within 24 months). A correction factor (CF) was the number reclassified divided by the number with a CD4 <350. Results: Of the 32 227 people diagnosed with HIV in EW&NI between 2011 and 2019 with a baseline CD4 (81% of total), 46% had a CD4 <350 (uncorrected late diagnosis rate): 34% of gay and bisexual men (GBM), 65% of heterosexual men, and 56% of heterosexual women. Accounting for recency test and/or prior negative tests gave a 'corrected' late diagnosis rate of 39% and corresponding CF of 14%. The CF increased from 10% to 18% during 2011–2015, then plateaued, and was larger among GBM (25%) than heterosexual men and women (6% and 7%, respectively). One‐year mortality among people diagnosed late was 329 per 10 000 after reclassification (an increase from 288/10 000). Conclusions: The case‐surveillance definition of late diagnosis increasingly overestimates late presentation, the extent of which differs by key populations. Adjustment of late diagnosis is recommended, particularly for frequent testers such as GBM. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

36. Artist Development and Collective Therapy in the Repertory: The Case of After Edward.

Author

Kirwan, Peter

Subjects
REPERTORY theater, REGIONAL theater, THEATERS
Abstract

This article discusses the exploration of the repertory model in Tom Stuart’s 2019 play After Edward, produced at Shakespeare’s Globe. Performed in repertory with a production of Edward II, After Edward dramatizes Diana Taylor’s sense of repertoire; the embodied skills of the actor and the heterochronic site of the Sam Wanamaker Playhouse allow Stuart as actor and writer to reconcile his lived experience as a gay man with his work as an actor. Based on this case study, this article argues that After Edward enacts a praxis of ensemble as artist development. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

37. Playing in Repertory.

Author

Tavares, Elizabeth, Johnson, Laurie, Barker, Roberta, MacLeod, Emily, Kirwan, Peter, and Fallow, Catriona

Subjects
REPERTORY theater, REGIONAL theater, EARLY modern English drama, EARLY modern English literature, LITTLE theater movement
Abstract

This introduction outlines the essays in the Early Theatre Issues in Review forum ‘Playing in Repertory’, placing them in the context of new movements in the study of early modern English repertories for contemporaneous and contemporary performance. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

38. Discriminating Between Premigration and Postmigration HIV Acquisition Using Surveillance Data

Author

Pantazis, Nikos Rosinska, Magdalena van Sighem, Ard Quinten, Chantal Noori, Teymur Burns, Fiona Martins, Helena Cortes and Kirwan, Peter D. O'Donnell, Kate Paraskevis, Dimitrios and Sommen, Cecile Zenner, Dominik Pharris, Anastasia

Subjects
virus diseases
Abstract

Background: Migrant populations are overrepresented among persons diagnosed with HIV in the European Union and the European Economic Area. Understanding the timing of HIV acquisition (premigration or postmigration) is crucial for developing public health interventions and for producing reliable estimates of HIV incidence and the number of people living with undiagnosed HIV infection. We summarize a recently proposed method for determining the timing of HIV acquisition and apply it to both real and simulated data. Methods: The considered method combines estimates from a mixed model, applied to data from a large seroconverters’ cohort, with biomarker measurements and individual characteristics to derive probabilities of premigration HIV acquisition within a Bayesian framework. The method is applied to a subset of data from the European Surveillance System (TESSy) and simulated data. Findings: Simulation study results showed good performance with the probabilities of correctly classifying a premigration case or a postmigration case being 87.4% and 80.4%, respectively. Applying the method to TESSy data, we estimated the proportions of migrants who acquired HIV in the destination country were 31.9%, 37.1%, 45.3%, and 45.2% for those originating from Africa, Europe, Asia, and other regions, respectively. Conclusions: Although the considered method was initially developed for cases with multiple biomarkers’ measurements, its performance, when applied to data where only one CD4 count per individual is available, remains satisfactory. Application of the method to TESSy data, estimated that a substantial proportion of HIV acquisition among migrants occurs in destination countries, having important implications for public health policy and programs.

Published
2021

39. The Shakespeare Apocrypha and canonical expansion in the marketplace

Author

Kirwan, Peter

Subjects
Dramatists -- Works, Shakespearean folios and quartos -- Authorship, Languages and linguistics, Literature/writing
Abstract

1 IN MARCH 2010, Brean Hammond's new edition of Lewis Theobald's Double Falsehood was added to the ongoing third series of the Arden Shakespeare, prompting a barrage of criticism in [...]

Published
2012

40. SHAKESPEARE PERFORMANCES IN ENGLAND, 2022.

Author

POTTER, LOIS and KIRWAN, PETER

Subjects
*SCHOLARLY method, *INTELLECTUAL life, *ACADEMIC etiquette, *CULTURE
Abstract

The article discusses various productions of Shakespeare's works in 2022 and how they portray the character of Shakespeare, often emphasizing the influence and contributions of women in his life. It mentions that recent scholarship has reimagined Shakespeare as a collaborator, and many productions have played with the text in ways that were once unthinkable.

Published
2023

41. A comparison of two frameworks for multi-state modelling, applied to outcomes after hospital admissions with COVID-19.

Author

Jackson, Christopher H, Tom, Brian DM, Kirwan, Peter D, Mandal, Sema, Seaman, Shaun R, Kunzmann, Kevin, Presanis, Anne M, and De Angelis, Daniela

Subjects
INTENSIVE care units, HOSPITAL admission & discharge, COVID-19, LENGTH of stay in hospitals, HAZARD function (Statistics), GOODNESS-of-fit tests
Abstract

We compare two multi-state modelling frameworks that can be used to represent dates of events following hospital admission for people infected during an epidemic. The methods are applied to data from people admitted to hospital with COVID-19, to estimate the probability of admission to intensive care unit, the probability of death in hospital for patients before and after intensive care unit admission, the lengths of stay in hospital, and how all these vary with age and gender. One modelling framework is based on defining transition-specific hazard functions for competing risks. A less commonly used framework defines partially-latent subpopulations who will experience each subsequent event, and uses a mixture model to estimate the probability that an individual will experience each event, and the distribution of the time to the event given that it occurs. We compare the advantages and disadvantages of these two frameworks, in the context of the COVID-19 example. The issues include the interpretation of the model parameters, the computational efficiency of estimating the quantities of interest, implementation in software and assessing goodness of fit. In the example, we find that some groups appear to be at very low risk of some events, in particular intensive care unit admission, and these are best represented by using 'cure-rate' models to define transition-specific hazards. We provide general-purpose software to implement all the models we describe in the flexsurv R package, which allows arbitrarily flexible distributions to be used to represent the cause-specific hazards or times to events. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

42. Tuberculosis incidence in country of origin is a key determinant of the risk of active tuberculosis in people living with HIV: Data from a 30‐year observational cohort study.

Author

White, Helena A., Okhai, Hajra, Kirwan, Peter, Rafeeq, Sonia H., Dillon, Helen, Hefford, Phillip, Wiselka, Martin J., and Pareek, Manish

Subjects
TUBERCULOSIS prognosis, TUBERCULOSIS epidemiology, TUBERCULOSIS risk factors, HIV-positive persons, KRUSKAL-Wallis Test, CONFIDENCE intervals, RETROSPECTIVE studies, PEARSON correlation (Statistics), INTERPROFESSIONAL relations, DESCRIPTIVE statistics, PROPORTIONAL hazards models
Abstract

Introduction: People living with HIV (PLWH) are at high risk of active tuberculosis (TB) but this risk in the era of antiretroviral treatment (ART) remains unclear. It is critical to identify the groups who should be prioritised for latent TB (LTBI) screening. In this study we identified the risk factors associated with developing incident TB disease, by analysing a 30‐year observational cohort. Methods: We evaluated PLWH in Leicester, UK, between 1983 and 2017 to ascertain those who developed active TB and the timing of this in relation to HIV diagnosis; whether before, concurrently with, or more than 3 months after the diagnosis of HIV (incident TB). Predictors of incident TB were ascertained using Cox proportional hazards models. Results: In all, 325 out of 2158 (15.1%) PLWH under care had had active TB; 64/325 (19.7%) prior to HIV diagnosis, 161/325 (49.5%) concurrently with/within 3 months of HIV diagnosis and 100/325 (30.8%) had incident TB. Incident TB risk was 4.57/1000 person‐years. Increased TB incidence in the country of birth was associated with an increased risk of developing incident TB [50–149/100 000 population, adjusted hazard ratio (AHR) = 3.10, 95% CI: 0.94–10.20; 150–249/100 000 population, AHR = 7.14, 95% CI: 3.46–14.74; 250–349/100 000 population, AHR = 5.90, 95% CI: 2.32–14.99; ≥ 350/100 000 population, AHR = 3.96, 95% CI: 1.39–11.26]. Conclusions: Tuberculosis risk remains high among PLWH and is related to TB incidence in the country of birth. Further work is required to determine whether specific groups of PLWH should be targeted for programmatic LTBI screening, and whether it will result in high uptake and completion of chemoprophylaxis and is cost‐effective for widespread implementation. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

43. SHAKESPEARE PERFORMANCES IN ENGLAND, 2021.

Author

POTTER, LOIS and KIRWAN, PETER

Subjects
*COVID-19 pandemic, *PLAY
Abstract

A personal narrative is presented where the author discusses his experience as an audience at the time of COVID-19 pandemic.

Published
2022

44. From the General Editor: Forgetting Shakespeare, Remembering Collaborators.

Author

Kirwan, Peter

Subjects
THEATER audiences, MISOGYNY, COVID-19 pandemic
Abstract

This editorial introduces the articles in issues 40.1 and 40.2, noting recurrent concerns with issues presented by the Shakespearean text in production; an interest in the mediating strategies used by Shakespearean institutions to communicate with audiences; and challenges to received knowledge. The editorial also welcomes new members of the editorial team and thanks collaborators who have supported the journal's work over the last year. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

45. COVID‐19 mortality among people with diagnosed HIV compared to those without during the first wave of the COVID‐19 pandemic in England.

Author

Brown, Alison E., Croxford, Sara E., Nash, Sophie, Khawam, Jameel, Kirwan, Peter, Kall, Meaghan, Bradshaw, Daniel, Sabin, Caroline, Miller, Robert F., Post, Frank A., Harding, Richard, Collins, Simon, Waters, Laura, Asboe, David, Chadwick, David R., Delpech, Valerie, and Sullivan, Ann K.

Subjects
HIV infection complications, HIV-positive persons, HIV infections, COVID-19, CONFIDENCE intervals, AGE distribution, BLACK people, RACE, REGRESSION analysis, RISK assessment, COMPARATIVE studies, SEX distribution, DESCRIPTIVE statistics, VIREMIA, COVID-19 pandemic, COMORBIDITY
Abstract

Objectives: We describe COVID‐19 mortality among people with and without HIV during the first wave of the pandemic in England. Methods: National surveillance data on adults (aged ≥ 15 years) with diagnosed HIV resident in England were linked to national COVID‐19 mortality surveillance data (2 March 2020–16 June 2020); HIV clinicians verified linked cases and provided information on the circumstances of death. We present COVID‐19 mortality rates by HIV status, using negative binomial regression to assess the association between HIV and mortality, adjusting for gender, age and ethnicity. Results: Overall, 99 people with HIV, including 61 of black ethnicity, died of/with COVID‐19 (107/100 000) compared with 49 483 people without HIV (109/100 000). Compared to people without HIV, higher COVID‐19 mortality rates were observed in people with HIV of black (188 vs. 122/100 000) and Asian (131 vs. 77.0/100 000) ethnicity, and in both younger (15–59 years: 58.3 vs. 10.2/100 000) and older (≥ 60 years: 434 vs. 355/100 000) people. After adjustment for demographic factors, people with HIV had a higher COVID‐19 mortality risk than those without (2.18; 95% CI: 1.76–2.70). Most people with HIV who died of/with COVID‐19 had suppressed HIV viraemia (91%) and at least one comorbidity reported to be associated with poor COVID‐19 outcomes (87%). Conclusions: In the first wave of the pandemic in England, COVID‐19 mortality among people with HIV was low, but was higher than in those without HIV, after controlling for demographic factors. This supports the strategy of prioritizing COVID‐19 vaccination for people with HIV and strongly encouraging its uptake, especially in those of black and Asian ethnicity. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

46. Development and function of human cerebral cortex neural networks from pluripotent stem cells in vitro

Author

Kirwan, Peter, Turner-Bridger, Benita, Peter, Manuel, Momoh, Ayiba, Arambepola, Devika, Robinson, Hugh PC, Livesey, Frederick J, Kirwan, Peter [0000-0003-1446-7544], Turner-Bridger, Benita [0000-0003-3718-3632], Robinson, Hugh [0000-0002-5048-9954], Livesey, Frederick [0000-0001-6128-3372], and Apollo - University of Cambridge Repository

Subjects
Cerebral Cortex, Pluripotent Stem Cells, Neuronal Plasticity, Patch-Clamp Techniques, Reverse Transcriptase Polymerase Chain Reaction, Dendritic Spines, Video Recording, Stem cells, In Vitro Techniques, Stem Cells and Regeneration, nervous system, Neural development, Microscopy, Fluorescence, Image Processing, Computer-Assisted, Humans, Networks, Nerve Net, Single-Cell Analysis, Human
Abstract

A key aspect of nervous system development, including that of the cerebral cortex, is the formation of higher-order neural networks. Developing neural networks undergo several phases with distinct activity patterns in vivo, which are thought to prune and fine-tune network connectivity. We report here that human pluripotent stem cell (hPSC)-derived cerebral cortex neurons form large-scale networks that reflect those found in the developing cerebral cortex in vivo. Synchronised oscillatory networks develop in a highly stereotyped pattern over several weeks in culture. An initial phase of increasing frequency of oscillations is followed by a phase of decreasing frequency, before giving rise to non-synchronous, ordered activity patterns. hPSC-derived cortical neural networks are excitatory, driven by activation of AMPA- and NMDA-type glutamate receptors, and can undergo NMDA-receptor-mediated plasticity. Investigating single neuron connectivity within PSC-derived cultures, using rabies-based trans-synaptic tracing, we found two broad classes of neuronal connectivity: most neurons have small numbers (40). These data demonstrate that the formation of hPSC-derived cortical networks mimics in vivo cortical network development and function, demonstrating the utility of in vitro systems for mechanistic studies of human forebrain neural network biology., Summary: Human PSC-derived cerebral cortex neurons form large-scale functional networks that change over time and mimic those found in the developing cerebral cortex in vivo.

Published
2015

48. Invasive Pneumococcal Disease in People With Human Immunodeficiency Virus in England, 1999–2017.

Author

Kirwan, Peter D, Amin-Chowdhury, Zahin, Croxford, Sara E, Sheppard, Carmen, Fry, Norman, Delpech, Valerie C, and Ladhani, Shamez N

Subjects
*STREPTOCOCCAL disease prevention, *HIV-positive persons, *CONFIDENCE intervals, *VIRAL load, *STREPTOCOCCAL diseases, *PNEUMOCOCCAL vaccines, *DISEASE incidence, *ANTIRETROVIRAL agents, *COMPARATIVE studies, *DESCRIPTIVE statistics, *ALGORITHMS, *ADULTS
Abstract

Background The 7-valent and 13-valent pneumococcal conjugate vaccines (PCVs) were introduced into the UK childhood immunization program in 2006 and 2010, respectively, with high effectiveness and resulting in both direct and indirect protection. We describe the epidemiology of invasive pneumococcal disease (IPD) in adults with human immunodeficiency virus (HIV) in England following the introduction of both PCVs. Methods Data on a national cohort of people with HIV were linked to confirmed IPD cases in adults aged ≥ 15 years during 1999–2017. Date of HIV infection was estimated using a CD4 slope decline algorithm. Results Among 133 994 adults with HIV, 1453 developed IPD during 1999–2017, with 70% (1016/1453) developing IPD ≥ 3 months after their HIV diagnosis. IPD and HIV were codiagnosed within 90 days in 345 (24%) individuals. A missed opportunity for earlier HIV diagnosis was identified in 6% (89/1453), mostly in earlier years. IPD incidence in people with HIV increased from 147/100 000 in 1999 to 284/100 000 in 2007 before declining and stabilizing between 92 and 113/100 000 during 2014–2017. Mean annual IPD incidence was lower among those receiving antiretroviral therapy during 2014–17 (68 vs 720/100 000; incidence rate ratio [IRR] 9.3; 95% confidence interval [CI], 7.3–11.8; P  < .001) and was markedly lower in those with a suppressed viral load (50 vs 523/100 000; IRR 10.4; 95% CI, 7.6–14.1; P  < .001). The latter group still had 4.5-fold higher (95% CI, 3.8–5.3; P  < .001) IPD incidence compared to the general population (11.2/100 000). Conclusions IPD incidence among people with HIV reduced after PCV13 introduction and has remained stable. Adults presenting with IPD should continue to be tested for HIV infection. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

49. From the New General Editor.

Author

Kirwan, Peter

Subjects
PERFORMANCE theory, FINANCE, COLLEGE teachers, SCHOLARS, COMMUNITIES
Abstract

The article presents the discussion on modern performance studies facing a number of existential challenges to the purpose and practices. Topics include funding models for both academia and the arts showing significant vulnerabilities resulting in mass unemployment; and enabling the international community of scholars coming together for attending the same productions and opening up shows to audiences.

Published
2021
Full Text
View/download PDF

50. Does being on HIV antiretroviral therapy increase the risk of syphilis? An analysis of a large national cohort of MSM living with HIV in England 2009-2016.

Author

Allen, Hester, Kirwan, Peter, Brown, Alison E., Mohammed, Hamish, Hughes, Gwenda, Marks, Michael, and Delpech, Valerie

Abstract

Objective: A resurgence in bacterial STIs, notably syphilis, among gay, bisexual and other men who have sex with men (MSM) has been detected in England. A Canadian modelling study postulated that antiretroviral therapy (ART) may increase susceptibility to syphilis. We assess the association between ART and syphilis incidence in a comprehensive national cohort of MSM living with HIV in England.Methods: National surveillance data were used to create a cohort of MSM attending for both HIV and STI care in England between 2009 and 2016. Survival analysis was used to calculate the incidence of infectious syphilis during periods on and off ART. Multivariable Poisson regression was used to assess the association between ART use and syphilis, after adjustment for potential confounders, including, as a proxy measure for high-risk behaviour, being diagnosed with >1 other STI prior to a syphilis diagnosis.Results: 19 428 HIV diagnosed MSM contributed 112 960 person-years of follow-up from 2009 to 2016. The overall rate of syphilis was 78.0 cases per 1000 person-years follow-up. Syphilis rates were higher among men receiving ART (36.8) compared with those who did not (28.4) (absolute rate difference 4.7 cases per 1000 person-years). Multivariable analysis showed no statistical association between receiving ART and syphilis. Increased risk of syphilis was found in MSM aged 25-34 (HR 1.89, 95% CI 1.43 to 2.51) and in those diagnosed with two other STIs (HR 5.83, 95% CI 5.37 to 6.32).Conclusion: While we observed a small increase in the rate of syphilis among those on ART, when adjusting for potential confounding factors, including a proxy measure for high-risk behaviour, there was no evidence of an increased risk of syphilis in MSM receiving ART. High-risk sexual behaviour markers were the main risk factors for syphilis, and our results highlight the need for STI prevention interventions in MSM living with HIV to target these particularly high-risk sexual networks. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results